MARIA ICIAR
ASTIGARRAGA AGUIRRE
PROFESORADO ASOCIADO
Cincinnati Children's Hospital Medical Center
Cincinnati, Estados UnidosPublicaciones en colaboración con investigadoras/es de Cincinnati Children's Hospital Medical Center (5)
2018
-
Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society
Journal of Allergy and Clinical Immunology: In Practice, Vol. 6, Núm. 5, pp. 1508-1517
-
Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis
Blood, Vol. 132, Núm. 19, pp. 2088-2096
2017
-
Confirmed efficacy of etoposide and dexamethasone in HLH treatment: Long-Term results of the cooperative HLH-2004 study
Blood, Vol. 130, Núm. 25, pp. 2728-2738
-
Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome
Journal of Pediatrics, Vol. 189, pp. 72-78.e3